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Abstract
Emergence of the resistance in microbial population is a major threat to both animal and
human health. In bovine, the development of microbial resistance is a persistent threat for
health especially in the form of zoonotic pandemics due to viral and multidrug bacterial
resistance. Mechanisms of antimicrobial resistance in microbes are of natural as well as
acquired origin. There are half dozen molecular mechanisms identified that possibly cause
the emergence and transfer of antimicrobial resistance within and between different
bacterial genera. These mechanisms include degradation of the antibacterial drug by the
bacterial enzymes, reduced permeability of the drug by bacteria, increased efflux of the
drug, modification of drug target and use of alternative pathways by bacterial cells.
Various assays viz. disk diffusion test and E-test, focusing on minimum inhibitory con-
centration of antimicrobials, have been employed to detect the antimicrobial resistance in
microbes. The most important factor responsible for the development of multidrug resis-
tance in bovine pathogenic microbes is irrational use of the antibiotics. Antibiotics are
necessary evil, so judicious use of antibiotics, early detection of infections, vaccination, use
of immune-modulators and medicinal plants or their derivatives are some of the strategies
to reduce the possible emergence of antimicrobial resistance.
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1. Introduction
Antimicrobial compounds include antibiotics as well as many other substances which are used
to kill or inhibit the growth (multiplication) of bacteria. But nowadays, many bacteria causing
diseases of pandemic (e.g., tuberculosis) importance are increasingly developing the resistance
against a myriad of the antimicrobial compounds which, in terms, is leading to the ineffective
treatment of many fatal human and animal disease outbreaks.
1.1. Antimicrobial resistance in microbes
The idea of using antimicrobial compounds was originally proposed by Paul Ehrlich in 1908
who proposed to use some chemicals which he originally thought as “magic bullet” to kill the
bacteria specifically with a minimum harm to the host (animals and humans). He used
SilverSan to treat an infectious disease in humans transmitted through sexual contact known
as syphilis. This was the first time that a chemical was used to treat the microbial infections.
Since the discovery of the first antibiotic, penicillin (1920s), researcher worked diligently to
find new antibiotics, and this leads to the discovery of many new antibiotics, e.g., tetracycline,
gentamicin, and chloramphenicol. Antibiotics are compounds which are produced by one
microbe, and they are used to kill the other microbial spp. So, till 1950 a majority of infectious
diseases in humans were treatable by using these antibiotics [1].
However, unfortunately, soon after the clinical use of antibiotics, a phenomenon was found in
Staphylococcus aureus by means of which it was no longer susceptible to penicillin. It started
producing an enzyme named as penicillinase, which can easily break down the beta lactam ring
of penicillin. This ring is necessary to bind bacteria (penicillin binding proteins; PBPs) and
therefore its bacterial killing ability. This effect was named as antimicrobial/antibiotic resistance
in bacteria. Since then, many different types of bacteria are becoming increasingly resistant to
many new antibiotics. The phenomenon of antibiotic resistance in bacteria is a persistently
ongoing process and is on rise with every new day. This process can further be increased by
humans, e.g., the inappropriate use of antibiotics, following reduced doses of antibiotics than
required/standards, using antibiotics as a precautionary measures in viral infections, using
antibiotics as growth promoters, prescribing broad-spectrum antibiotics, using antibiotics with-
out using the antimicrobial sensitivity testing, and finally by noncompliance of the animal
owner. There has been a surge in the use of antibiotics for treatment of a variety of infections. In
fact, nowadays, the use of a variety of anti-infection therapy has become an invaluable tool for
the treatment of a variety of bovine infections. Using anti-infective agents has greatly reduced the
mortality as well as the morbidity against a variety of microbial infections in animals and
humans. However, their frequent use has also led to a major problem in human and animal
health, the development of antimicrobial resistance in microbes (ability of a microorganism to
tolerate and even grow in the presence of the normal inhibitory concentration), and its transmis-
sion to a variety of other microbes (within same or different genera) against these anti-infective
agents. The development of the resistance in microbes against anti-infective agents was predict-
able as the discoverer of the first antibiotic, Dr. Alexander Fleming, discussed this issue in his
Nobel prize winning lecture (1945) [2, 3].
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The emergence of the antibiotic-resistant strains has been associated with an increased occur-
rence of the morbidity and mortality by the antibiotic-resistant isolates than caused by the
nonresistant isolates in both humans and animals. In the last 6 decades, there has been a
tremendous increase in the number of the multidrug-resistant (MDR) isolates in bacterial
community, which have been associated with an increase in hospital stay in humans. Nowa-
days, with an advent of a variety of molecular biology techniques, there have been several
mechanisms reported for the development of the resistance in the bacterial populations
infecting humans and animals, and this process is ever increasing. Therefore, it is extremely
important to know the factors that cause antibiotic resistance in humans and animals, molec-
ular mechanisms of the antimicrobial resistance in different microbes, different methods of the
genetic transfer of the resistance among different microbes, and the development of a variety
of strategies for the control of bacterial resistance against antimicrobials, so that a better control
of the infections in humans as well as in animals can be made.
2. Common bovine infections and their treatment
Currently, in Indo-Pak numerous infectious diseases are prevalent in bovines. Because these
are the major source of income for the poor farmers (who merely raise about 4–5 animals),
there is massive irregular use of a variety of anti-infectious agents to save their life and thus
family earnings. Whereas, in Table 1, a list of diseases and their possible treatments in bovines
is given.
3. Factors associated with antimicrobial resistance in animals
Since the discovery of the first antibiotic, penicillin, by Alexander Fleming, there has been a
tremendous use of antibiotics in farm animals. In animals, antibiotics have been used as growth
promoters as prophylaxis as well as metaphylaxis. Both approaches involve the administration
of antibiotics in animals either by injection or through feed/water.
The primary goal of antibiotics was to treat the infectious diseases in animals and, thereby,
improve the overall health of animals and humans. However, an unexpected thing observed in
chickens during the 1940s was that antibiotic use may also cause an increase in the growth rate
Infection/disease Etiology Treatment options
Hemorrhagic septicemia Pasteurella multocida Oxytetracycline
Anthrax Bacillus anthracis Penicillin
Black leg/quarter Clostridium chauvoei Penicillin
Contagious bovine Pleuropneumonia Mycoplasma mycoides Tylosin
Table 1. Common bovine infections and their treatment.
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in animals. This finding has led to their use as growth promoters. Antibiotics have been used
as growth promoters for decades. This aspect is of tremendous controversy since the begin-
ning. The practice employs the use of antibiotics at subtherapeutic levels, with the main
purpose to control the enteric and respiratory diseases in farm animals associated with poor
management. The exact mechanism by which antibiotic may enhance the growth rate in
animals is yet unknown precisely; however, it is postulated that antibiotics may increase the
animal growth rate by either one of the following mechanisms:
a. Killing the pathogenic bacterial species in the intestine and thereby reducing the inflam-
matory conditions
b. Reduced inflammation in the intestinal mucosa leading to the increased absorption of the
variety of nutrients from the intestinal tract
c. Increasing the amount of beneficial microbes in the intestinal tract leading to an optimal
intestinal environment
d. Synthesis of a variety of bacteriocins (bacterial products made by beneficial bacteria or
probiotics which are used to inhibit other pathogenic microbes) and vitamins by the
probiotics further increasing animal health
Currently, China, the USA, and Brazil are the leading countries of antibiotic utilization in
animals. Approximately, 40 antibiotics have been approved for animals in the USA, out of
which more than 30 are currently being used in humans. Majority of antibiotic use in animals
falls in either one of the three uses:
3.1. For the treatment of infectious diseases in animals (therapeutic use)
Therapeutic treatment usually involves the treatment of either single or whole herd/flock with
specific doses of specific antimicrobial drugs. One typical care should be kept in mind in this
aspect is that each animal should receive the complete dose of antibiotics and the antibiotic
treatment should be continued for at least 72–120 h. But there may be problems in this aspect
of antibiotic use as the diseased animal has greatly reduced appetite, and this thing may lead
to the reduced intake of the specific antibacterial drug. This may lead to the potential problem
of developing the resistance in microbial communities against these antibiotics [4].
3.2. For the prevention of a variety of infections in animals (prophylactic use)
Traditionally many antibiotics were being used in the feed lot and dairy cattle to prevent
against a variety of diseases. However, this practice is discouraged.
3.3. The use of antibiotics as growth promoters
Although the use of antibiotics in animals has greatly contributed in increasing the produc-
tion in farm animals, however, their use as growth promoter was an issue of great contro-
versy as this practice has greatly enhanced the development of resistance in a variety of
microbial species not only in animals but also in humans. Therefore, nowadays, several
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countries have banned the use of the latest antibiotics as growth promoters in animals (to be
intended for human use only in order to minimize the chances for development of antimi-
crobial resistance) [5, 6].
There are some exceptions in this aspect of development of the resistance in microbial commu-
nities against antimicrobial use as AGPs. The typical example is the use of ionophores which
are mainly used to reduce the incidence of coccidiosis as well as improve the microbial
communities in rumen (favor the microbial communities toward Gram-positive bacteria).
Furthermore, latest studies have also shown that the use of the AGPs may contribute toward
the disturbance of normal microflora in animals, thereby greatly affecting the immune system
of the animals [7–10].
4. Molecular mechanisms of the resistance against major antimicrobial
drugs
Although, till now, different types of the resistance mechanisms have been reported in bacteria
against different antibiotics, they can be broadly classified as follows.
4.1. Degradation of the antibacterial drug by the bacterial enzymes
Several bacterial beta lactamases can degrade the beta lactam antibiotics. Beta lactamases do it so
by degrading the beta lactam ring of the antibiotics. Also, some antibiotics can be degraded by
the addition of the specific group, e.g., chloramphenicol molecule possesses hydroxyl group that
can be easily acetylated by the incorporation of acetyl-CoA, a reaction that is catalyzed by acetyl
transferases. Moreover, aminoglycosides can also be easily degraded by the addition of phos-
phate, acetyl-CoA, and adenylyl group, and these additions are carried out by the phosphotr-
ansferases, acetyl transferases and the adenyl transferases [11, 12].
4.2. Reduced permeability to a drug by bacteria
For example, most of the Gram negatives contain extremely small-sized porin in their outer
membrane, and this imparts a major permeability barrier to a large number of antibiotics to
cross that barrier. In similar manner, Mycobacterium also offers a major permeability barrier to
most of the antibiotics as they contain a thick layer of the mycolic acid, and this waxy material
hinders the entry of the majority of drugs [13].
4.3. Increased efflux of the drug
Several bacterial species possess the efflux pumps that actively pump out the drug by bacterial
cells. Such pumps effectively reduce the bactericidal concentration of a particular antibiotic
drug, and they have been actively implicated in the emergence of resistance against a myriad
of the antibiotics particularly against tetracyclines, aminoglycosides, and sulfonamides. The
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examples of bacteria containing these types of pumps include Pseudomonas, Staphylococcus
aureus, and E. coli [14].
4.4. Modification of the drug target
Several drugs act by their initial binding to a particular site within bacterial cells in order to
initiate their bactericidal/bacteriostatic activity. So when a drug binding target is changed, it
may lead to the development of the resistance in bacteria against that drug. This phenomenon
has been incriminated in the emergence of the resistance against antibiotics such as macrolides
and phenolics (Chloramphenicol) in which alternations in the binding sites at ribosome dras-
tically reduce the antibacterial activity of these drugs [15].
4.5. Use of an alternative pathway by bacterial cells
Some of the microbes use alternate pathways, and they change the previous pathway which is
inhibited by a particular antibiotic. Typical example is that some of the bacteria use the
preformed folic acid rather than synthesizing it, which is inhibited by sulfonamides by a
phenomenon known as competitive antagonism.
4.6. Specific analysis of antibiotic resistance at molecular level
With an advent of the molecular biology techniques, many mechanisms for the development of
antibiotic resistance have been observed in the last half century [2]. One of the major threats
nowadays is by the extended spectrum beta lactamases (ESBLs) producing Gram-negative
bacteria [11]. Till now, approximately 13,000 different types of the ESBLs have been reported,
and they are mainly classified into three different functional groups. Most of the ESBLs are
encoded by a gene known as bla, and the most important ones are bla CTX, bla TEM, bla SHV,
bla KPC, and bla OXA. One of the major issues is the origin of the carbapenemase enzymes
which are mainly associated with the development of the resistance in the carbapenems (e.g.,
IMP, KPC, VIM beta lactamases, and OXA), major drugs which are used for the treatment of
multidrug-resistant (MDR) Gram-negative infections. These enzymes also act on the third- and
fourth-generation cephalosporins, e.g., cefquinome and ceftiofur, thus referred as the extended
spectrum cephalosporinases (ESCs). One of the major features associated with many ESBLs/
ESCs is that they are located in the moveable genetic elements, e.g., plasmids [12]. In similar
way, resistance to macrolides is also associated with the development of the resistance in a
variety of closely related drugs, i.e., lincosamides, pleuromutilins, and streptogramins, and
thus they are referred as PLSA phenotype [16, 17] and MLSB phenotype [18].
Another main point associated with the aminoglycoside resistance is that the same gene in
bacteria is responsible for resistance against the gentamicin and apramycin. Moreover it has
also been observed that the gene causing the resistance against the aminoglycoside is also
responsible for the resistance against the fluoroquinolones [19].
The table below illustrates the different mechanisms of the development of the resistance
against a variety of anti-infection drugs used in veterinary medicine. This table clearly depicts
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that each bacterium possesses a unique set of the resistance mechanisms, and virtually resis-
tance against antibiotics is present in nearly all species. One such example is that the resistance
against the macrolide is different in Staphylococcus than observed in the Campylobacter.
One of the major emerging issues nowadays is the resistance against multiple drugs, i.e.,
fluoroquinolones and cephalosporins; another such issue is the emerging MDR E.coli ST 131
[20, 21]. Some of the old antibiotics, e.g., colistin, which was previously widely used for the
control of E. coli [21], have been withdrawn so that it may be used to treat a variety of infections
caused by the MDRGram-negative bacterial spp. [22]. However, recently it has been observed in
China that bacteria possess the mcr-1 gene which plays an important role in conferring resistance
against colistin, and this observation has severely raised questions on the use of colistin for the
treatment of a variety of bacterial infections [23–25]. Just immediately afterward, in Belgium,
mcr-2 gene was also observed in a bacterium that did not contain the mcr-1 gene and that gene
was also responsible for conferring the resistance against colistin in those bacteria [26, 27].
Another important fact is that the emergence of the resistance against one member of a class of
antibiotic may result in the development of the resistance against other members of that class. The
other mechanism is known as co-selection. This is a phenomenon in which the genes for resistance
against a myriad of antibiotics are located in the single plasmid or the mobile genetic element. In
this case this mobile genomic element or the plasmid confers the resistance against all the
antibiotics. In contrary to this, the other mechanism is that when one bacterium becomes resistant
against one microbe, then it exhibits an increased susceptibility against the other antibiotic [28].
4.6.1. Mechanisms of the antibacterial drug resistance
Table 2 illustrates the mechanisms of the bacterial resistance against different drugs. It also
depicts various genes involved in the emergence of resistance against that drug.
4.7. Mechanisms of antibacterial resistance transfer in bacteria
One of the major problems is that bacteria not only become resistant to many antibacterial
drugs by a variety of phenomena, but they are also capable of transferring this resistance to
other bacteria of same as well as with other genera. The main reason for transfer of genetic
resistance is because the genes for antibacterial resistance are mainly present on the moveable
genomic elements (MGE), e.g., integrons, plasmids, and transposons. But the changes at gene
level may also occur in chromosomes although they are extremely rare (except in Mycobacte-
rium). This often occurs because there is a change in the drug target and, thus, the antibacterial
drug cannot bind to the appropriate binding site, leading to the loss of efficacy of that partic-
ular antibiotic. If the use of antibiotics is inappropriate, e.g., not following the well-established
dosage regimen for a particular drug against a particular disease, it can dramatically increase
the chances of the development of the resistance against that drug because of the selective
advantage of changing their genomic elements.
One of the main important locations of antibacterial resistance is the bacterial plasmids.
Plasmids are single covalently closed circular pieces of the DNA which are not important in
the survival of the bacteria, but they are extremely important in offering an added advantage
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Antibiotic class Members Target Resistance
mechanism
Genes involved
(examples)
Polypeptide Bacitracin Cell wall (inhibits peptidoglycan
synthesis)
Efflux Bcr
Tetracycline Tetracycline
Oxytetracycline
Chlortetracycline
Doxycycline
Minocycline
Ribosome (30 S) Drug efflux
Change in binding
site
Drug modification by
bacterial enzymes
Otr, tet
Streptogramins Virginiamycin Ribosome Efflux
Change in drug target
Drug inactivation by
bacterial enzymes
Erm, Isa, Vgb,
Vga, cfr, vat
Macrolides Tylosin
Tilmicosin
Tiamulin
Erythromycin
Azithromycin
Clarithromycin
Spiramycin
Tulathromycin
Ribosome (50 S; inhibit the
translocation of the aminoacyl tRNA
from P site to A site)
Glycosylation
Hydrolysis
Phosphorylation
Efflux
Altered drug target
Ere, erm, msr,
mef, mph, cfr
Pleuromutilins Valnemulin Ribosomes Altered drug target
Efflux of the drug
Sal, cfr, vga, isa
Lincosamides Lincomycin
Clindamycin
Ribosome (50 S; Inhibit the
translocation of the aminoacyl tRNA
from P site to A site)
Drug efflux
Inactivation of the
drug
Altered drug target
Erm, inu, vga,
inu, cfr, msr,
Beta lactams Penicillin
Amoxicillin
Ampicillin
Cloxacillin
Cefuroxime
Cefalexin
Ceftiofur
Cefquinome
Cell wall (inhibit the synthesis of
peptidoglycan)
Efflux,
Hydrolysis
Altered drug target
Ade, mec, bla,
mex, cme
Aminoglycosides Gentamicin
Kanamycin
Neomycin
Apramycin
Spiramycin
Framycetin
Ribosomes Inactivation by
bacterial enzymes
Efflux
Altered drug target
Aph, ant, acc,
rmt, ade, arm,
spd, apw
Fluoroquinolones Enrofloxacin
Marbofloxacin
Orbifloxacin
Ibafloxacin
Pradofloxacin
DNA replication
(inhibit the DNA gyrase)
Altered drug target
Drug efflux
Inactivation of the
drug by the bacterial
enzymes
Aac (60), oqx,
qnr, gyr A, parC
Phenicols Florfenicol
Chloramphenicol
Ribosomes (50 S; inhibit the
peptidyltransferase)
Drug efflux
Inactivation of the
drug by enzymes
Altered drug target
Cat, cfr, cml, flo,
optr
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to the microbes when present. They do it by providing the genes for resistance against many
antibacterial drugs. Moreover, they can also make the bacteria resist the toxins and heavy
metals. Because of the fact that they are important in providing the bacteria resistance against
many factors, that is why they are also called as R factor. Plasmids are extremely important in
the development of the resistance against the drugs as they can easily be transferred from one
to the other bacteria by means of the pilus. This process is known as conjugation. This process
can occur in many species including Clostridium, E. coli, Bordetella, Salmonella, Proteus, Strepto-
coccus, and Shigella. One important factor should be kept in mind that plasmids may not only
be transmitted within a genus but also between genera. This fact is of extreme danger to the
bovine as well as public health as resistance in bovine microbial spp. can transfer the resistance
in many microbes of public health importance, sometimes even leading to the pandemic
spread of the zoonotic and public health pathogens.
However, it should be kept in mind that although the plasmids are often exchanged between
bacteria by the process of conjugation, however, they may also be transmitted from one to the
other bacteria by means of other methods of genetic transfer, and they may include the
transduction and transformation. In transformation, the genetic components of one bacterium
are transmitted to the other bacterium when placed in a medium. However, it should be kept
in mind that this process is poorly understood, yet at molecular level and moreover, it occurs
in limited microbes under specific conditions (the presence of divalent ions or electrical
pulses).
Transduction is defined as the transfer of genetic components from one to another bacterium
through a bacteriophage (viruses infecting bacteria). When a virus infects the bacterial cells,
there is possibility that during integration with the host cell genome, it may take away some
components of those bacterial cells in the process when it leaves the cells. Two types of
transduction are possible. One is generalized transduction in which any component of the
Antibiotic class Members Target Resistance
mechanism
Genes involved
(examples)
Sulfonamides Sulfamethoxazole Folic acid synthesis Altered drug target
Increase efflux of the
drug
acr, sul
Nitrofurans Nitrofurazone
Nitrofurantoin
DNA Modification of the
target in bacteria
Changes in porins
Omp, nfs
Pyrimidines Trimethoprim Folic acid synthesis Modification of the
target in bacteria
Enhance drug efflux
Dhfr, bpr-opc
Cationic
polypeptides
Colistin
Polymyxin B
Cell membrane Modification of the
drug target
Increased efflux of the
drug
pmr AB, mgr
Table 2. Mechanisms of the antibacterial drug resistance.
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bacterial cell may be transmitted. On the other hand, the specialized transduction is one in
which the virus carries only the specific component of the bacterial cells (mostly surrounding
portion of the integration site). When the same bacteriophage may infect the other cell, it can
transfer the genes of previous bacteria into the new bacteria. The process of transduction
occurs with the greatest frequency in gram-positive bacteria.
A single plasmid may carry the genes for antibacterial resistance against many drugs (3–9);
thus, the whole population of the bacteria may become multidrug resistant by the process of
plasmid transfer although the animals may be treated with only one drug. A single plasmid
has been found to carry the genes of antibacterial drug resistance at against least nine different
drugs.
Other MGEs may also play an important role in the emergence of antibacterial resistance in
microbial populations. Many transposons may also carry the genes for antibacterial drug
resistance, and they are rapidly moving within the bacteria leading to the emergence of
antibacterial drugs resistance in microbes. Some examples of the transposons include the
Tn05 (bleomycin, kanamycin, and streptomycin), Tn21 (spectinomycin, streptomycin, and
sulfonamides), and Tn4001 (tobramycin, gentamicin, and kanamycin).
A genetic component that carries many genes against many antibiotics together in the form of
gene cassettes is also known as integrons. An integrin is normally a nonreplicating piece of the
DNA that is often associated with a plasmid, chromosomes, or integrons. The integrons also
play an important role in the spread of antibiotic resistance against many microbes as they are
also easily transmitted from one to the other bacterial spp.
4.8. Determination of antibiotic susceptibility
Although antibiotics have been made many years ago, however, still little information is
available on how to use antibiotics in which way. Although there are many guidelines about
the treatment of specific infections with specific antimicrobial agents, however, still it is often
extremely difficult to select an appropriate antibiotic to treat a particular disease. This happens
primarily as many factors contribute to the selection of an appropriate antibiotic, and they
include animal species affected (some antibiotics are contraindicated in bovine because of
public health issues, or they are too much toxic for animals),the infection (aerobic or anaerobic,
soft tissue or hard tissue infection), microorganism susceptibility to a particular agent, drug
behavior within the body (pharmacodynamics, e.g., where the drug distributes more effec-
tively and toxicity profile of the drug within the body), dosage regimen of particular antibiotic,
route of administration, and various drug residues. Majority of the mentioned parameters are
studied in depth while designing and final approval of the drug, but still pharmacodynamics
of a particular drug are often unpredictable in some animals and the site of infection also
matters in the selection of antibiotics.
So, testing antimicrobial compounds to determine the antimicrobial susceptibility in various
bacteria becomes an extremely important parameter to be determined, before making a final
decision about the antibiotic use in animals. On the basis of the results of the antibiotic
sensitivity testing, the organisms may be classified as the susceptible, intermediate, or resistant
microorganisms. However, an important aspect should be kept in mind that antibiotic is not
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equally effective against all bacteria even if they belong to the same spp. A typical example is
Pasteurella multocida, which causes the respiratory infection in bovines. When its (isolated from
many animals from different countries) antibiotic susceptibility was done against ampicillin,
then different isolates demonstrated different levels of the susceptibility and resistance against
the same drug (Penicillins). In addition, it is possible that an antibiotic is initially highly effective
in the treatment of a particular infection; however, with the passage of time, its effectiveness may
become lower. This problem may arise if the animal is treated many times with the same
antibiotic or is exposed to the suboptimal concentration of a particular antibiotic.
So because of this intense variation in antibiotic response against different infections, it
becomes imperative to accurately test the antibiotic susceptibility routinely prior to make any
decision. The results provided by some of the routinely used antibiotic susceptibility tests can
provide some guidance about the susceptibility profile of bacteria against different antibiotics.
However, it should also be kept in mind that although these in vitro antibiotic profile may
provide us with an idea of bacterial antibiotic susceptibility testing, however, still they do not
provide any guarantee to be effective in vivo. A simpler scenario may be that when animals is
suffering from an anaerobic infection in which E. coli is primarily the causative organisms,
in vitro test may show that aminoglycosides possess good antibacterial activity against the E.
coli; however, if only the interpretation of that result is kept in mind and aminoglycosides are
used to threat that infection, there will be treatment failure. This is because of the fact that
aminoglycosides need oxygen-based uptake within the bacteria, and in anaerobic environ-
ment, there is no uptake of the aminoglycosides leading to the failure of treatment. Similarly,
different drugs have different affinities for different tissues, and thus if some drug is unable to
reach to a particular tissue, it is unable to demonstrate its microbial killing or inhibition
activity. Moreover, nowadays a very hot research issue is how to control bacterial population
in biofilms. Different bacteria make biofilms which are collections of millions of the microbes.
In biofilms, microbial population becomes extremely resistant to a particular drug, as it does
not allow the drug to penetrate the microbial populations. In short various factors are respon-
sible for an antimicrobial drug to demonstrate different antibacterial effects in vitro and
in vivo.
Although the assays for the determination of the antimicrobial sensitivity were developed just
after the discovery of the first antibiotic, penicillin, however, they were poorly designed assays,
and they exhibited a greater variability not only among different communities but within the
same hospital. So there was a pressing issue for the development of the test which exhibits
greater reproducibility and may be applied universally across the globe. So after a lot of hit and
trial method, researcher became successful in devising an assay which is used till now as one of
the most preferred methods for the determination of the antibiotic susceptibility testing in
microbes. This test was developed by Bauer in 1966 and is known as disk diffusion assay of
antimicrobial sensitivity in microbes.
4.8.1. Disk diffusion test for antimicrobial sensitivity
This is one of the most widely assays currently being used in veterinary medicine because this
assay can be used to test the antimicrobial activity of many drugs against any bacterial spp.,
and it is also economical.
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The test is based on the use of disk impregnated with antibacterial compound and placing it on
the agar plate (Muller Hinton agar) which is cultured with 1  108 microorganisms/ml of the
suspension. When the antibiotic disk is placed on the agar surface, it allows the antibiotic to
move in a lateral position due to diffusion. This results in the generation of the antibiotic
gradient along the agar surface. Near the antibiotic disk, the concentration of the antibiotic is
higher, but as the distance increases from the disk, it causes a reduced concentration of the
antibiotic. This results in the production of the zone of inhibition of the bacterial growth. This
zone gives an indirect idea for the estimation of the minimum inhibitory concentration of the
drug that is required against particular bacterium.
The disk diffusion method can also be affected by many different types of factors. The first one
is the thickness of the agar in the petri plate. The recommended thickness of agar medium is
4 mm. If the thickness of the agar medium is more than the recommended thickness, it will
result in the reduced diffusion of the drug in lateral direction, resulting in false interpretation
of the antimicrobial sensitivity test. If the thickness of the plate is less than the recommended
thickness, it will result in increased drug diffusion in the lateral direction. The second factor is
the bacterial concentration. If the bacterial concentration in the media is less than the
recommended, it will result in an increased zone of inhibition, which leads to the false inter-
pretation of the test. Similarly, if the concentration of the bacterial suspension is more than the
standard one, it will also mislead the final interpretation. If the generation time of the micro-
organism is too long, e.g., Arcanobacterium, it will result in an increased zone of inhibition
leading to a false interpretation. Another factor to be kept in mind while conducting antibiotic
sensitivity testing is the placement of the disks on agar. The standard distance is 24 mm. If the
distance is too small between two antibiotic disks, it may lead to overlap among various zones
of inhibition making the interpretation of the assay difficult.
One major disadvantage of this test is that this assay is mainly qualitative. Although it gives us
an idea about the minimum inhibitory concentration of a particular drug against a particular
microbe, however, still it is one of the most commonly used particularly in developing coun-
tries, where infrastructure is poor at local veterinary hospitals. The other advantage of this test
is that it is an extremely simpler test to carry out with a minimum cost. The results of this assay
are available within 24–48 h for most of the bacterial pathogens of bovine importance [29].
4.8.2. E-test
The other method of determination of antibiotic sensitivity is the E-test. The disadvantage of
the disk diffusion assay can be mitigated by using another similar test which almost involves
the same technique; however, it gives a nearly realistic value of the MIC of particular antibi-
otics against a particular bacterium. The test is named as E-test.
The principle of the E-test is based on the lateral diffusion of the drug from a plastic strip
which is impregnated with the different conc. of the antibiotics usually starting from 0. Along
the length of the plastic strip, the concentration of the antibiotic increases gradually, thus
creating a continuous gradient of antibiotic concentration along the plastic strip.
So at the beginning where the concentration of antibiotic is zero, there is usually no zone of the
inhibition. As the concentration of the antibiotic increases, there is a proportional increase in
the zone of inhibition around the plastic strip.
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Although E-test gives us quantity data regarding the MIC against a particular bacterium,
however, it is expensive to carry out, which makes it difficult to be carried out under field
conditions; however, it may be used for research purpose against a particular bacterium [30].
4.9. Strategies to reduce the antimicrobial resistance
As development of antibiotic resistance in major microbes is posing a major threat to animal
and human populations, it requires efforts at gross root level to reduce this problem. Several
different strategies may be adopted which are extremely important for the reduction in the
emergence of antibacterial resistance. This may involve the early detection and diagnosis of the
infectious diseases, the use of alternatives to antibiotics, estimation of the cost and relative
benefit analysis, and using immunomodulation.
4.9.1. Early detection and diagnosis of diseases
This strategy may also aid a lot in the reduction of antimicrobial use and thus develop
resistance as discussed; see [29]. Several diseases have different parameters, which may give
an important indicator about the disease occurrence at an earlier stage. For example, several
liver enzymes and kidney enzymes start to alter their serum conc. And this may provide an
initial indicator for a variety of infectious diseases at earlier stages. Several infectious diseases
produce systemic indicators, such as increase in the serum proteins, and this effect is collec-
tively known as acute phase response to an infection. In acute phase response, several acute
phase proteins are greatly increased in their serum concentration. Similarly at initial stages of
viral and bacterial infection, there are changes in the conc. of the specific cytokines in the
serum of an animal. All of these acute phase proteins and changes in the levels of the different
cytokines can easily be detected by a variety of laboratory tests (e.g., ELISA). Although this
approach requires a state-of-the-art diagnostic laboratory facility, using this approach can help
in the reduction of the emergence of the antibiotic residues in bovines. All of these changes in
earlier stages of infection are the consequences of systemic inflammatory response which can
easily be controlled by the use of a variety of anti-inflammatory drugs, i.e., nonsteroidal anti-
inflammatory drugs. This treatment can be augmented by using the strategy of nutritional
modulation in dairy animals by supplementing feed with omega-3 fatty acid, phytochemicals
(e.g., Aloe arborescence, Echinacea purpurea), and antioxidants. It has been observed that using
this strategy can lead to the reduction in the incidence of many reproductive diseases, ketosis,
and somatic cell count in milk.
The above strategy may be adopted with a greatest success in terms of the reduction of the
antibiotics use in animals, but this strategy also necessitates the routinely strict monitoring and
inspection of the dairy herd. A variety of animal welfare and health parameters should be
regularly monitored, and they include recording the dry matter intake of animals, milk
somatic cell count, rectal temperature, the presence of blood or fibrin clots in milk, and noting
any teat lesions. It has been observed that routine monitoring of these parameters can result in
earlier detection of the disease and therefore earlier and simpler treatments, often not requiring
antibiotics (e.g., by improving the ruminal activity with the use of yeast or glucogenic supple-
mentation).
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4.9.2. Using antibiotic alternatives
Recently, it has been proposed in the international OIE conference that an emphasis should be
placed on the use of antibacterial drug alternatives such as bacteriophages, biological response
modifiers (BMRs), antibacterial peptides of natural origin, prebiotics, probiotics, and the use of
proper vaccination schedule in animals (given in the table below); probiotics, prebiotics, and
BRMs are responsible for the development of the optimal intestinal microbial flora which can
overall improve the animal health along with reducing the incidence of the several infectious
diseases in dairy animals; see [31–33]. Bacteriophages are extremely specific in infecting par-
ticular bacteria, and that is why they pose a minimum toxicity danger in humans and animals,
yet this approach is mainly on theoretical grounds and needs many successful clinical trials
and intensive knowledge before they may be adapted in animals for treating infectious dis-
eases. Similarly following an appropriate vaccination program in animals (keeping in view of
the serotype/strain of the agent to be used in a particular area) can dramatically reduce the
occurrence of many primary as well as secondary infections in bovines.
Table 3 illustrates a variety of diseases and their treatment.
Vaccinating the bovine against many infectious diseases can definitely reduce the incidence of
majority of bacterial and viral infections, thereby further reducing the usage of the antimicro-
bials in bovine.
Similarly, using a variety of phytochemicals may also be useful in the treatment of variety of
infections. These chemicals derived from different plants act systemically for the treatment of
diseases.
For treating the infections of gastrointestinal tract, Allium sativum stem is crushed, is boiled in
the water, and then is provided to the animals. Its effect is mainly due to the compound
present in it also known as allicin which is well known for its antibacterial activity [34, 35].
Also Cassia fistula is also being used in treating a variety of GIT maladies of bovines; particu-
larly, it is effective in treating E. coli infections effectively. This activity may be due to the
presence of several compounds of pharmacological importance including terpenoids, sapo-
nins, steroids, anthraquinone, phenolic compounds, and steroids present in them [36]. Simi-
larly seeds of the Foeniculum vulgare are mixed with the root of Glycyrrhiza glabra, and they are
also used to treat the GIT infections [37, 38]. Morus alba leaves are given to the animals for
Brucellosis (breeding animals) 4–12 months of age
Vibriosis (breeding animals) Before breeding
Leptospirosis (breeding animals) Before breeding
Black leg March
Anthrax February–August
Hemorrhagic septicemia June–December
Foot-and-mouth disease March–September
Table 3. Vaccination schedule of bovine.
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5 days in order to treat constipation. This anticonstipation activity is mainly reported because
of the presence of the quercetin, rutin, and apigenin [39, 40]. Punica granatum peel has also
demonstrated its activity against majority of the GIT pathogens which may be because of the
presence of the flavonoids and phenolic compounds in it [41].
One of the most economically devastating diseases of bovine, mastitis, can also be treated by
using a variety of phytochemicals. Here again, Allium sativum is also routinely being used in
the treatment of mastitis. It has shown promising results even against those pathogens which
are resistant to many antibiotics [42]. Zingiber officinale is also being used to control mastitis in
dairy animals [43]. Similarly, Allium cepa and Trachyspermum ammi mixture was also being
routinely used to control mastitis successfully in dairy herds [44].
Bovine often do suffer from a myriad of respiratory infections particularly when kept in a
closed humid confinement in winter season and with poor ventilation. Again some com-
pounds are extremely useful in treating respiratory diseases of animals, and they include
Glycyrrhiza glabra (stem) and Hordeum vulgare (seeds). Both of these plants possess a variety
of compounds such as saponins, volatile compounds, tannins, and alkaloids which are
beneficial in treating a variety of mild to moderate respiratory infections (when treated for
5–7 days) [45, 46].
Similarly for the treatment of a variety of bovine skin infections, many compounds are rou-
tinely used, and they include Aloe barbadensis leaves (given orally alone or mixing with salts),
Tamarix aphylla leaves (applied topically), Citrullus colocynthis (extracts from fruit and seed),
and Azadirachta indica (leaves). All of these plants are extremely useful in treating a variety of
inflammatory/infectious diseases of bovine skin [47–49].
4.9.3. Estimation of the cost and relative benefit analysis
Although currently there is a great emphasis on the reduction of antibiotic use in animals,
however, its use is still needed in some cases of infectious diseases. But in such cases, it is better
to prioritize the basis of cost of antibiotics in animals and the benefits achieved. For example, in
the case of mastitis, treatment efficacy with the help of gram-negative bacteria depends on
several factors including the bacterial spp. involved and the acuteness or chronicity of the
disease. Some cases have good outcomes following treatment, while the treatment of the chron-
ically affected animals is often futile. Similarly, some bacterial spp., e.g., Streptococcus agalactiae
and Staphylococcus aureus, along with coagulase-negative Staphylococcus aureus, are extremely
difficult to treat. This also implies that culturing of the mastitis-infected milk along with antibi-
otic susceptibility testing should be a routine practice while treating the animals; see [50].
Similarly if the animal is repeatedly suffering from clinical mastitis, particularly after the third
lactation, then mostly cost of the treatment becomes extremely higher than the benefits.
4.9.4. Immunomodulator use
Animals often suffer from chronic stress when their welfare is compromised. Stress may be in
the form of overcrowding, nutritional deficiency, poor ventilation and temperature control,
transportation, and high production. Under stress body physiology is altered, and it results in
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secretion of cortisol from the adrenal cortex. Under the influence of the adrenal cortisol, the
body immune system is greatly compromised. This predisposes the animals to a variety of
infectious diseases. So it is better to use immunomodulators in animals under the conditions of
stress. This strategy has been discussed in detail; see [51, 52]. These immunomodulators may
include the use of vitamins A, C, and E along with minerals such as selenium, copper, and
many other minerals. This can dramatically reduce the incidence of many infectious diseases in
dairy animals leading toward a reduced use of antibiotics in animals.
5. Conclusion
There are numerous aspects of antibiotic resistance in animals, which are important public health
threats for humans, and therefore it is imperative to make as many possible efforts to reduce the
emergence of antibiotic resistance in farm animals. It may involve maintaining the animal welfare
and good nutritional and immunological status, routine examination of the herd, early detection
and appropriate diagnosis of infectious diseases in animals, appropriate therapy at time and the
use of antibiotic alternatives such as bacteriophages and vaccination, the use of phenomena of
competitive exclusion (by using pre-, pro-, and synbiotics), biological response modifiers, and
appropriate immunomodulation in animals. Implementing such programs at national level
requires huge financial and political support for ongoing efforts to effectively control the emer-
gence of antibacterial resistance in major bacterial spp. Although using these approaches may not
completely assure the avoidance of antibiotics and, therefore, the possibility of emergence of
antibiotics, yet, these approaches may aid in slowing down the antibiotic resistance to a greater
extent in animals leading toward a great step in improving the public health.
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